9
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Oral transmucosal fentanyl citrate: a novel agent for breakthrough pain related to cancer

&
Pages 625-629 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kyriaki Mystakidou, Eleni Tsilika, Marinos Tsiatas & Lambros Vlahos. (2007) Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. International Journal of Nanomedicine 2:1, pages 49-54.
Read now
Kyriaki Mystakidou, Emmanuela Katsouda, Efi Parpa, Lambros Vlahos & Marinos L. Tsiatas. (2006) Oral Transmucosal Fentanyl Citrate: Overview of Pharmacological and Clinical Characteristics. Drug Delivery 13:4, pages 269-276.
Read now

Articles from other publishers (7)

A.-M. Kuivalainen, F. Ebeling & P.H. Rosenberg. (2013) Pre-medication with sublingual fentanyl did not relieve pain associated with bone marrow aspiration and biopsy: A randomized feasibility trial. European Journal of Pain 17:9, pages 1357-1364.
Crossref
Donald R TaylorDonald Taylor. 2013. Managing Cancer Breakthrough Pain. Managing Cancer Breakthrough Pain 29 66 .
Frank Porecca & Tamara KingMellar P Davis. 2012. Analgesics for Cancer Pain. Analgesics for Cancer Pain 42 59 .
R. Zarth, M. Ehmer & H.-B. Sittig. (2007) Oral-transmukosales Fentanylcitrat zur Therapie von DurchbruchschmerzenOral transmucosal fentanyl citrate for the treatment of breakthrough pain. Der Schmerz 21:6, pages 545-552.
Crossref
Diane Laverty. (2007) Treating cancer-related breakthrough pain: the oral transmucosal route. International Journal of Palliative Nursing 13:7, pages 326-331.
Crossref
Diane Laverty. (2007) Actiq: an effective oral treatment for cancer-related breakthrough pain. British Journal of Community Nursing 12:7, pages 311-316.
Crossref
Michelle Rhiner, Guadalupe Palos & Maria Termini. (2004) Managing Breakthrough Pain: A Clinical Review With Three Case Studies Using Oral Transmucosal Fentanyl Citrate. Clinical Journal of Oncology Nursing 8:5, pages 507-512.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.